FDA releases draft guidance to spur development of CDI drugs
Regulatory NewsJoanne S. Eglovitch
Clinical TrialsComplianceNorth AmericaPharmaceuticalsQuality Assurance and ControlRegulatory Intelligence/PolicyRegulatory NewsJoanne S. EglovitchClinical TrialsComplianceNorth AmericaPharmaceuticalsQuality Assurance and ControlRegulatory Intelligence/Policy